Prevalence of hepatitis G virus (HGV) in high-risk groups and blood donors in Tehran, Iran

Iranian Journal of Public Health

Volumn 34, Issue 4, 2005, Pages 41-46

  Amini, S ^a   Mahmoodabadi, S Andalibi ^a   Lamian, S ^a   Joulaie, M ^a   Farahani, M Mahmoodi ^b  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood donor; GB virus C; HGV; Iran; IVDU; Thalassemia

Indexed keywords

VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG USE; FEMALE; GENE SEQUENCE; GENETIC CODE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HEPATITIS G; HEPATITIS G VIRUS; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; INFECTION RISK; IRAN; MAJOR CLINICAL STUDY; MALE; POPULATION DISTRIBUTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEROPREVALENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THALASSEMIA;

EID: 31744442411     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Linnen J, Wages Jr, Zhang-Keck ZY, et al. (1996). Molecular cloning and disease association of hepatitis G virus: a transfusion transmissible agent. Science, 271: 505-8.
2. Liu H-F, Cornu C, Jadoul M, Dahan K, Loute G, Goubau P (1998). Molecular analysis of GB virus C isolates in Belgian hemodialysis patients. J Med Virol, 55: 118-22.
3. Dawson GJ, Schlauder GG, pilot-Matias TJ, et al. (1996). Prevalence studies of GB virus-C infection using reverse transcriptase- polymerase chain reaction. J Med Virol, 50: 97-103.
4. Quarleri JF, Oubina JR (1997). A proposed rapid method for genomic characterization of GBV-C/ hepatitis G virus (HGV) Medicina B Aires, 57: 717-19.
5. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989). Isolation of cDNA clone derived from blood-borne non-A, non-B viral hepatitis genome. Science, 244:359-62.
6. Yoshiba M, Okamoto H, Mishiro S (1995). Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown origin. Lancet, 346:1131-2.
7. Tanaka E, Alter HJ, Nakatsuji Y, et al. (1996). Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med, 125 (9): 740-43.
8. Scheicher S, Ricardo L, Dehmer T, Gregor M, Hess G, Flehmig B (1996). Identification of GBV-C hepatitis G RNA in chronic hepatitis C patients. J Med Virol, 50:71-4.
9. De Lamballerie X, Charrel RN and Dussol B (1996). Hepatitis GB virus C in patients on haemodialysis. N Engl J Med. 334 (23):1549.
10. Aikawa T, Sugal Y, Okamoto H (1996). Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med, 334(3):195-96.
11. Wu RR, Mizokami M, Cao K, et al. (1997). GB virus C/hepatitis G virus infection in southern China. J Infect Dis, 75:168-71.
12. Lefrere JJ, Mariotti M, Lerable J, Thauvin M, Girot R (1996). Long-term persistence of hepatitis G virus in immuno-competent patients. Lancet, 348(9035): 1174-75.
13. Barlet V, Zarski JP, Thelu MA, Seigneurin JM (1991). Advantage of PCR for detecting low amount of HBV-DNA in patients sera. Res Virol, 142:373-79.
14. Stuyver L, Rosssau R, Wyseur A, et al. (1993). Typing of hepatitis C virus isolated characterization of new subtypes using a line probe assay. J General Virol, 74:1093-102.
15. Poovorawan Y, Theamboonlers A, Chongsrisawat V, Jantaradsamee P (1998). Prevalence of infection with hepatitis G virus among various groups in Thailand. Ann Trop Med Parasitol, 92(1):89-95.
16. Anastassopoulou CG, Paaskevi D, Sypsa V, et al. (1998). Prevalence patterns and genotypes of GB virus/ hepatitis G virus among imprisoned intravenous drug users. J Med Virol, 56: 246-52.
17. Cacopardo B, Berger A, Cosentino S, et al (1998). Serum hepatitis G virus (HGV) RNA in multi transfused Thalassemics from Eastern Sicily. J Infect, 36:179-83.
18. Shamshirsaz AA, Bekheirnia MR, Kamgar M, et al. (2003). Metabolic and endocrinologic complications in beta-thalassemia major: a multi center study in Tehran. BMC Endocr Disord, 3 (1): 4.
19. Zali MR, Mayumi M, Raoufi M, Nowroozi A (1999). GBV-C infection among patients with Hepatitis C virus in the Islamic Republic of Iran: a preliminary report. East Mediterr Health J, 5(5): 1023-29.
20. Fiordalisi G, Zanella I, Mantero G, et al. (1996). High prevalence of GB virus C infection in a group of Italian patients with hepatitis of unknown etiology. J Infect Dis, 174(1):181-83.
21. Oliverira LA, Martins R MB, Carneiro M AS, et al. (2002). Prevalence and genotypes of GB virus C/ hepatitis G virus among blood donors in central Brazil. Mem Inst Oswaldo Cruz, 97 (7): 953-57.
22. Levi JE, Contri DG, Lima LP, et al. (2003). High prevalence of GB virus C/ Hepatitis G virus RNA among Brazilian blood donors. Rev Inst Med Trop S Paulo, 45 (2): 75-8.
23. Hadziyannis SJ, Dawson GJ, Verttou E, Gioustozi A, Schlaunder GG, Deasi SM (1995). Infection with the novel GB-C virus in multiply transfused patients and in various forms of chronic liver diseases. Abstract from: 46th Annual Meeting and Postgraduate Course of the American association for the study of Liver Diseases. Chicago (Illinois, USA). Hepatology, 22: 218A.
24. Tagariello G, Infantolino D, Biasin MR, Davoli PG, Traldi A (1996). Hepatitis G viral RNA in Italian hemophiliaces with and without hepatitis C infection. Lancet, 34: 760-61.
25. Diamatis I, Bassetti s, Erb P, Ladewing D, Gyr K, Battegay M (1997). High prevalence and co-infection rate of hepatitis G and C infection in intravenous drug addicts. J Hepatol, 26: 794-7.
26. Tacke M, Kiyosawa K, Stark K, et al. (1997). Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet, 349(9053): 736.
27. Shev S, Bjorkman P, Norkrans G, et al. (1998). GBV-C/HGV infection in heaptitis C virus infected deferred Swedish blood donors. J Med Virol, 54(2): 75-9.